(Q35635985)

9 August 2017

1 reference

title

Update on pharmacotherapy of borderline personality disorder (English)

1 reference

borderline personality disorder

9 August 2017

0 references

0 references

1

Mary C Zanarini

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Current Psychiatry Reports

9 August 2017

published in

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

66-70

1 reference

An Inventory for Measuring Depression

9 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-004-0041-9

Axis I Comorbidity of Borderline Personality Disorder

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-004-0041-9

Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder

21 January 2018

1 reference

12 December 2020

Fluoxetine trial in borderline personality disorder

1 reference

12 December 2020

SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder

1 reference

12 December 2020

Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years

1 reference

12 December 2020

Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.

1 reference

12 December 2020

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

1 reference

12 December 2020

Venlafaxine in the treatment of borderline personality disorder

1 reference

12 December 2020

An open trial of valproate in borderline personality disorder

1 reference

12 December 2020

Divalproex sodium as a treatment for borderline personality disorder

1 reference

12 December 2020

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

12 December 2020

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

1 reference

12 December 2020

SCL-90: an outpatient psychiatric rating scale--preliminary report

1 reference

12 December 2020

A rating scale for mania: reliability, validity and sensitivity

1 reference

12 December 2020

A psychobiological perspective on the personality disorders

1 reference

12 December 2020

Treatment utilization by patients with personality disorders.

1 reference

12 December 2020

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

The diagnostic interview for borderline patients

1 reference

12 December 2020

Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior

1 reference

12 December 2020

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Treatment of borderline personality disorder with risperidone

1 reference

12 December 2020

Fluoxetine in borderline personality disorder

1 reference

12 December 2020

Treatment histories of borderline inpatients

1 reference

12 December 2020

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

1 reference

12 December 2020

Clozapine treatment of borderline patients: a preliminary study

1 reference

12 December 2020

Fluoxetine in the treatment of borderline and schizotypal personality disorders

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

10.1007/S11920-004-0041-9

Identifiers

DOI

1 reference

9 August 2017

1 reference